<description>In this episode, we take a closer look at tirzepatide, a type 2 diabetes medication also used to help with weight loss. Postmenopause weight gain can be a normal part of aging, and there are some questions about whether medications like tirzepatide could be useful and safe for postmenopausal women. Host Aaron Lohr talks with <strong>Maria Daniela Hurtado Andrade, MD, PhD</strong>, assistant professor of medicine at Mayo Clinic Florida, and <strong>Regina Castaneda, MD</strong>, a research fellow at Mayo Clinic College of Medicine &amp; Science. They presented an abstract at ENDO 2025 titled, “One-Year Real-World Weight Loss Outcomes with Tirzepatide in Postmenopausal Women With and Without Hormone Therapy.” Show notes are available at <a href="https://www.endocrine.org/podcast/enp105">https://www.endocrine.org/podcast/enp105</a> — for helpful links or to hear more podcast episodes, visit <a href="https://www.endocrine.org/podcast">https://www.endocrine.org/podcast</a></description>

Endocrine News Podcast

Endocrine Society

ENP105: Tirzepatide and Menopause

OCT 29, 202518 MIN
Endocrine News Podcast

ENP105: Tirzepatide and Menopause

OCT 29, 202518 MIN

Description

In this episode, we take a closer look at tirzepatide, a type 2 diabetes medication also used to help with weight loss. Postmenopause weight gain can be a normal part of aging, and there are some questions about whether medications like tirzepatide could be useful and safe for postmenopausal women. Host Aaron Lohr talks with Maria Daniela Hurtado Andrade, MD, PhD, assistant professor of medicine at Mayo Clinic Florida, and Regina Castaneda, MD, a research fellow at Mayo Clinic College of Medicine & Science. They presented an abstract at ENDO 2025 titled, “One-Year Real-World Weight Loss Outcomes with Tirzepatide in Postmenopausal Women With and Without Hormone Therapy.” Show notes are available at https://www.endocrine.org/podcast/enp105 — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast